Designer drugs 2,5‐dimethoxy‐4‐bromo‐amphetamine (DOB) and 2,5‐dimethoxy‐4‐bromo‐methamphetamine (MDOB): studies on their metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques
Authors:
- 9 February 2006
- journal article
- research article
- Published by Wiley in Journal of Mass Spectrometry
- Vol. 41 (4) , 487-498
Abstract
Studies are described on the metabolism and the toxicological analysis of the amphetamine‐derived designer drug 2,5‐dimethoxy‐4‐bromo‐amphetamine (DOB) and its corresponding N‐methyl analogue 2,5‐dimethoxy‐4‐bromo‐methamphetamine (MDOB) in rat urine using gas chromatographic/mass spectrometric techniques. The identified metabolites indicated that DOB was metabolized by O‐demethylation followed by oxidative deamination to the corresponding ketone as well as deamination followed by reduction to the corresponding alcohol. Other metabolic pathways were O,O‐bisdemethylation or hydroxylation of the side chain followed by O‐demethylation and deamination to the corresponding alcohol. The expected oxo compound after deamination could not be detected. All metabolites carrying hydroxy groups were found to be partly excreted in the conjugated form. MDOB underwent O‐demethylation, O,O‐bisdemethylation, or hydroxylation of the side chain followed by O‐demethylation. Additional N‐demethylation to DOB occurred, including the above‐mentioned metabolites. Again, all metabolites carrying hydroxy groups were found to be partly excreted in the conjugated form. The authors' systematic toxicological analysis (STA) procedure using full‐scan GC/MS after acid hydrolysis, liquid–liquid extraction, and microwave‐assisted acetylation allowed the detection of an intake of a dose of DOB and MDOB in rat urine that corresponds to a common drug user's dose. Assuming a similar metabolism, the described STA procedure in human urine should be suitable as proof of an intake of DOB and MDOB. Copyright © 2006 John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Studies on the metabolism and toxicological detection of the designer drug 4-methylthioamphetamine (4-MTA) in human urine using gas chromatography–mass spectrometryJournal of Chromatography B, 2005
- New designer drug 2,5‐dimethoxy‐4‐ethylthio‐β‐phenethylamine (2C‐T‐2): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometryJournal of Mass Spectrometry, 2005
- New designer drug, 2,5‐dimethoxy‐4‐propylthio‐β‐phenethylamine (2C‐T‐7): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometryJournal of Mass Spectrometry, 2005
- Dihydrobenzofuran Analogues of Hallucinogens. 3. Models of 4-Substituted (2,5-Dimethoxyphenyl)alkylamine Derivatives with Rigidified Methoxy GroupsJournal of Medicinal Chemistry, 1996
- Methcathinone: A new and potent amphetamine-like agentPharmacology Biochemistry and Behavior, 1987
- Bromo-DMA: The Australasian Hallucinogen?Australian & New Zealand Journal of Psychiatry, 1983
- A Death Due to 4-Bromo-2,5-dimethoxyamphetamineClinical Toxicology, 1981
- Potential psychotomimetics. BromomethoxyamphetaminesJournal of Medicinal Chemistry, 1971
- Gas‐chromatographische Charakterisierung organischer Verbindungen. Teil 1: Retentionsindices aliphatischer Halogenide, Alkohole, Aldehyde und KetoneHelvetica Chimica Acta, 1958
- DIAZOHYDROCARBONSCanadian Journal of Research, 1950